TW200618807A - Prevention and therapeutical agent for hepatitis C virus infection - Google Patents

Prevention and therapeutical agent for hepatitis C virus infection

Info

Publication number
TW200618807A
TW200618807A TW094137130A TW94137130A TW200618807A TW 200618807 A TW200618807 A TW 200618807A TW 094137130 A TW094137130 A TW 094137130A TW 94137130 A TW94137130 A TW 94137130A TW 200618807 A TW200618807 A TW 200618807A
Authority
TW
Taiwan
Prior art keywords
polygala
virus infection
hepatitis
extract
prevention
Prior art date
Application number
TW094137130A
Other languages
English (en)
Inventor
Tatsuya Ito
Masahiro Aoki
Masayuki Sudoh
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of TW200618807A publication Critical patent/TW200618807A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/69—Polygalaceae (Milkwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
TW094137130A 2004-10-25 2005-10-24 Prevention and therapeutical agent for hepatitis C virus infection TW200618807A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004309196 2004-10-25

Publications (1)

Publication Number Publication Date
TW200618807A true TW200618807A (en) 2006-06-16

Family

ID=36227915

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094137130A TW200618807A (en) 2004-10-25 2005-10-24 Prevention and therapeutical agent for hepatitis C virus infection

Country Status (3)

Country Link
JP (1) JPWO2006046674A1 (zh)
TW (1) TW200618807A (zh)
WO (1) WO2006046674A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109580829A (zh) * 2018-12-28 2019-04-05 成都康美药业生产有限公司 一种远志中远志山酮iii和3,6-二芥子酰基蔗糖的检测方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009046465A (ja) * 2007-07-23 2009-03-05 Maruzen Pharmaceut Co Ltd 皮膚化粧料及び飲食品
KR101162710B1 (ko) * 2009-01-23 2012-07-05 (주) 비엔씨바이오팜 도라지 추출물 또는 도라지 사포닌 화합물을 함유하는 ｃ형 간염의 예방 또는 치료용 약학적 조성물
TWI410431B (zh) 2010-12-22 2013-10-01 Ind Tech Res Inst 齊敦果酸衍生物在製備預防或治療ｃ型肝炎之藥物的用途
CN108159126A (zh) * 2018-02-13 2018-06-15 广东药科大学 瓜子金皂苷提取物在制备抗肿瘤药物中的应用
WO2020085799A1 (ko) * 2018-10-23 2020-04-30 주식회사 온사이언스 도라지 사포닌을 포함하는 표준화된 도라지 추출물 또는 막분리 도라지 사포닌 추출물을 함유하는 간질환의 예방 또는 치료용 약학적 조성물 및 간기능 개선용 건강기능식품

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411733A (en) * 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
JPH07206694A (ja) * 1994-01-17 1995-08-08 Tsumura & Co 肝炎治療薬
JPH10130162A (ja) * 1996-10-31 1998-05-19 Kanebo Ltd ヒアルロン酸分解阻害剤、ヒアルロン酸異常分解疾患治療剤および化粧料
US6241995B1 (en) * 1997-08-08 2001-06-05 University Of Saskatchewan Polygala senega compositions and methods of use
TW586935B (en) * 1998-09-14 2004-05-11 Kitasato Inst Saponin-containing vaccine preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109580829A (zh) * 2018-12-28 2019-04-05 成都康美药业生产有限公司 一种远志中远志山酮iii和3,6-二芥子酰基蔗糖的检测方法

Also Published As

Publication number Publication date
WO2006046674A1 (ja) 2006-05-04
JPWO2006046674A1 (ja) 2008-05-22

Similar Documents

Publication Publication Date Title
WO2004002999A3 (en) Modified 2' and 3' -nucleoside produgs for treating flaviridae infections
WO2005020884A3 (en) Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses
WO2006044968A3 (en) Combination therapy for treating viral infections
AU2003301190A1 (en) Administration of capsaicinoids
TW200718418A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
EA200601467A1 (ru) Макроциклические соединения в качестве ингибиторов вирусной репликации
HK1072541A1 (en) Trans-epicutaneous administration form for treating restless leg syndrome
WO2002078627A3 (en) N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
TW200618807A (en) Prevention and therapeutical agent for hepatitis C virus infection
UA91677C2 (ru) Макроциклические соединения как ингибиторы вирусной репликации
MY137752A (en) Medicament for treating aseptic inflammations containing anemonin as effective component
UA92498C2 (ru) Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм
EP1201236A8 (en) Medicinal compositions for preventing or treating viral myocarditis
WO2005065639A3 (en) Novel pharmaceutical compositions
WO2005097618A3 (en) Low dose therapy for treating viral infections
CA2504872A1 (en) Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
MY141506A (en) Virus therapeutic drug
BRPI0414518A (pt) composições farmacêuticas e métodos compreendendo combinações de derivados de 2-alquilideno-19-nor-vitamina d e hormÈnio paratireoidiano
PT1220676E (pt) Prevencao do cancro colorrectal
MX2009006311A (es) Terapia de combinacion para tratar infecciones de hepatitis c.
UA95299C2 (ru) Профилактический или терапевтический агент против вирусного заболевания, вызванного вирусом гепатита с
WO2003026570A3 (en) Reduced toxicity cisplatin formulations and methods for using the same
ATE454896T1 (de) Heilkräuterzusammensetzung zur behandlung von aids
MD3121F1 (en) Method of viral hepatitis B prophylaxis
AU2000250568A1 (en) Herbal composition for the treatment and curing of diseases